Viemed Healthcare (VMD) Depreciation & Amortization (CF) (2018 - 2026)

Viemed Healthcare (VMD) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $7.6 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 15.24% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.6 million (up 15.27% YoY) and the FY2025 annual result came in at $28.6 million, up 12.79% from the prior year.
• Depreciation & Amortization (CF) improved to $7.6 million in Q1 2026, from $7.6 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $7.6 million in Q1 2026 to a low of $3.4 million in Q1 2022.
• A 5-year average of $5.8 million and a median of $6.3 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) jumped 44.99% — and 2025, when it advanced 5.22%.
• Tracing VMD's Depreciation & Amortization (CF) over 5 years: stood at $4.4 million in 2022, then soared by 35.35% to $5.9 million in 2023, then climbed by 7.55% to $6.4 million in 2024, then increased by 18.91% to $7.6 million in 2025, then gained by 0.67% to $7.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $7.6 million (Q1 2026), $7.6 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.